NCT03506399 - A Study of Lanabecestat in Healthy Female Participants Taking Oral Contraceptive | Biotech Hunter

Timeline

Start Date

June 30, 2018

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2018

Conditions

Healthy

Interventions

DRUG

Lanabecestat

Administered orally

DRUG

Oral Contraceptive

Administered orally

Trial Locations (1)

138623

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Singapore